Clinical Efficacy of Albumin-bound Paclitaxel in the Second-line Treatment of Recurrent Small Cell Lung Cancer

LIANG Feng; ZHU Tienian; ZHANG Yimei; LIU Jiankun

doi:10.3969/j.issn.1002-3429.2023.06.010

Home>Articles>Clinical Efficacy of Albumin-bound Paclitaxel in the Second-line Treatment of Recurrent Small Cell Lung Cancer

DOI: 10.3969/j.issn.1002-3429.2023.06.010

Clinical Efficacy of Albumin-bound Paclitaxel in the Second-line Treatment of Recurrent Small Cell Lung Cancer

LIANG Feng

ZHU Tienian

ZHANG Yimei

LIU Jiankun

Keywords：Small cell lung carcinomaAlbumin-bound paclitaxelProgression-free survivalMyelosuppressionLeukopeniaNeutropeniaDecreased hemoglobinDrug toxicity

Publication Date：2023-06-22

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 39-43 )

Clinical Misdiagnosis & Mistherapy

ISTIC

ISSN：1002-3429

Year, Vol.(Issue)：2023,36(6)